{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:46Z","timestamp":1791357286890,"version":"4.3.1"},"reference-count":130,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2015.00242","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T19:56:43Z","timestamp":1445630203000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer"],"prefix":"10.3389","volume":"6","author":[{"given":"Kedar S.","family":"Prabhavalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimmy B.","family":"Poovanpallil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh K.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2004.09.016","article-title":"Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats","volume":"1029","author":"Ahmad","year":"2004","journal-title":"Brain Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1177\/0269881110376695","article-title":"Lamotrigine: when and where does it act in affective disorders? A systematic review","volume":"25","author":"Amann","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists","volume":"57","author":"Anand","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00000542-199702000-00021","article-title":"Lamotrigine inhibits extracellular glutamate accumulation during transient global cerebral ischemia in rabbits","volume":"86","author":"Bacher","year":"1997","journal-title":"Anesthesiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1385\/MN:32:2:173","article-title":"Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics","volume":"32","author":"Bachmann","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2009.03.022","article-title":"Mood stabilizing drugs lamotrigine and olanzapine increase expression and activity of glutathione S-transferase in primary cultured rat cerebral cortical cells","volume":"455","author":"Bakare","year":"2009","journal-title":"Neurosci. Lett."},{"key":"B7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4088\/JCP.v63n0813","article-title":"Lamotrigine as an augmentation agent in treatment-resistant depression","volume":"63","author":"Barbee","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4088\/JCP.v64n0407","article-title":"A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes","volume":"64","author":"Barbosa","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/00127893-200203000-00002","article-title":"New antiepileptic drugs","volume":"8","author":"Bazil","year":"2002","journal-title":"Neurologist"},{"key":"B10","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1074\/jbc.275.11.7583","article-title":"Glycogen synthase kinase-3\u03b2 facilitates staurosporine- and heat shock-induced apoptosis: protection by lithium","volume":"275","author":"Bijur","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2174\/138945009789735138","article-title":"The role of sodium channels in the mechanism of action of antidepressants and mood stabilizers","volume":"10","author":"Bourin","year":"2009","journal-title":"Curr. Drug. Targets"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hup.657","article-title":"Treatment of acute mania-from clinical trials to recommendations for clinical practice","volume":"20","author":"Bourin","year":"2005","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.4088\/jcp.8125tx2c","article-title":"Treatment strategies for bipolar depression","volume":"71","author":"Bowden","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl. 4","key":"B15","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1016\/s0924-977x(99)00024-3","article-title":"Lamotrigine in the treatment of bipolar depression","volume":"9","author":"Bowden","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1517\/14656566.2012.741590","article-title":"Lamotrigine (Lamictal IR) for the treatment of bipolar disorder","volume":"13","author":"Bowden","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group","volume":"60","author":"Calabrese","year":"1999a","journal-title":"Clin. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0924-977X(99)00023-1","article-title":"Controlled trials in bipolar I depression: focus on switch rates and efficacy","volume":"9","author":"Calabrese","year":"1999b","journal-title":"Neuropsychopharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003a","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 2","key":"B20","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0924-977X(03)00079-8","article-title":"Latest maintenance data on lamotrigine in bipolar disorder","volume":"13","author":"Calabrese","year":"2003b","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","article-title":"Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials","volume":"10","author":"Calabrese","year":"2008","journal-title":"Bipolar Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0165-0327(98)00161-X","article-title":"Current research on rapid cycling bipolar disorder and its treatment","volume":"67","author":"Calabrese","year":"2001","journal-title":"J. Affect. Disorder."},{"key":"B23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group","volume":"61","author":"Calabrese","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0014-2999(91)90144-F","article-title":"Clonidine causes antidepressant-like effects in rats by activating \u03b12-adrenoceptors outside the locus coeruleus","volume":"193","author":"Cervo","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.pnpbp.2010.07.020","article-title":"Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers","volume":"34","author":"Chang","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s11064-008-9817-3","article-title":"Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex","volume":"34","author":"Chang","year":"2009","journal-title":"Neurochem. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neubiorev.2010.01.002","article-title":"Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance","volume":"34","author":"Cherlyn","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0920-1211(92)90065-2","article-title":"An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels","volume":"13","author":"Cheung","year":"1992","journal-title":"Epilepsy Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.bjp.0701796","article-title":"Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo","volume":"124","author":"Clifford","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/sj.npp.1300451","article-title":"Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder","volume":"29","author":"Clinton","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.euroneuro.2006.01.003","article-title":"Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test","volume":"16","author":"Consoni","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/S0028-3908(00)00051-4","article-title":"The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro","volume":"39","author":"Cunningham","year":"2000","journal-title":"Neuropharmacology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/01.jcp.0000204332.64390.f3","article-title":"Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results","volume":"26","author":"Daban","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"B34","first-page":"285","article-title":"On the role of noradrenergic neurotransmission in the action of desipramine and amitriptyline in animal models of depression","volume":"38","author":"Danysz","year":"1986","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3\u03b2 phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"B36","first-page":"389","article-title":"Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants","volume":"29","author":"Delgado","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJM199606133342407","article-title":"New antiepileptic drugs","volume":"334","author":"Dichter","year":"1996","journal-title":"N. Engl. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1399-5618.2004.00164.x","article-title":"Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons","volume":"7","author":"Di Daniel","year":"2005","journal-title":"Bipolar Disord."},{"key":"B39","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1523\/JNEUROSCI.23-19-07311.2003","article-title":"The role of the extracellular signal-regulated kinase signaling pathway in mood modulation","volume":"23","author":"Einat","year":"2003","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jad.2008.06.019","article-title":"Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep","volume":"111","author":"Endicott","year":"2008","journal-title":"J. Affect. Disord."},{"key":"B41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1017\/S1461145711001003","article-title":"Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder","volume":"15","author":"Epolia","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4088\/JCP.v58n1202","article-title":"Lamotrigine in rapid-cycling Bipolar Disorder","volume":"58","author":"Fatemi","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1113\/jphysiol.2004.077388","article-title":"Kainate receptors and rhythmic activity in neuronal networks: hippocampal gamma oscillations as a tool","volume":"562","author":"Fisahn","year":"2005","journal-title":"J. Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/00004714-200012000-00004","article-title":"A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders","volume":"20","author":"Frye","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1038\/sj.npp.1301387","article-title":"Increased anterior cingulate\/medial prefrontal cortical glutamate and creatine in bipolar depression","volume":"32","author":"Frye","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"94","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"B47","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"PT"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00241-x","article-title":"Bipolar disorder","author":"Grande","year":"2015","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"B49","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/s0165-0327(02)00339-7","article-title":"Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder","volume":"72","author":"Grunze","year":"2002","journal-title":"J. Affect. Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/0278-5846(91)90011-O","article-title":"Behavioural models in mice implication of the alpha noradrenergic system","volume":"15","author":"Hascoet","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000028396","article-title":"Glutathione S-transferase polymorphisms and their biological consequences","volume":"61","author":"Hayes","year":"2000","journal-title":"Pharmacology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11920-010-0156-0","article-title":"New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions","volume":"12","author":"Henry","year":"2010","journal-title":"Curr. Psychiatry Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4088\/JCP.v62n0406","article-title":"Antidepressant-induced mania in bipolar patients: identification of risk factors","volume":"62","author":"Henry","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.euroneuro.2004.03.003","article-title":"Lamotrigine: a depression mood stabilizer","volume":"14","author":"Herman","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/YIC.0b013e32832775fe","article-title":"Feasibility of a slower lamotrigine titration schedule for bipolar depression: a naturalistic study","volume":"24","author":"Joe","year":"2009","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"B59","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/FTD.0000000000000088","article-title":"Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigineaugmentation therapy in treatment-resistant depressive disorder","volume":"36","author":"Kagawa","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"B60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejphar.2007.03.003","article-title":"Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system","volume":"565","author":"Kaster","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpsychires.2008.02.007","article-title":"Effectiveness of lamotrigine in bipolar disorder in a clinical setting","volume":"43","author":"Ketter","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4088\/JCP.v63n0210","article-title":"Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature","volume":"63","author":"Ketter","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/01.jcp.0000088915.02635.e8","article-title":"Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders","volume":"23","author":"Ketter","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/mp.2009.137","article-title":"Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients","volume":"16","author":"Kim","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0028-3908(83)90024-2","article-title":"Involvement of \u03b1- and \u03b21-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test","volume":"22","author":"Kitada","year":"1983","journal-title":"Neuropharmacology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1046\/j.1528-1157.2001.04501.x","article-title":"Effectiveness of first antiepileptic drug","volume":"42","author":"Kwan","year":"2001","journal-title":"Epilepsia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1042\/BST0371080","article-title":"Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine","volume":"37","author":"Large","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"B68","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11064-007-9526-3","article-title":"Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex","volume":"33","author":"Lee","year":"2008","journal-title":"Neurochem. Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0006-8993(92)90598-4","article-title":"Chronic lithium administration alters a prominent PKC substrate in rat hippocampus","volume":"570","author":"Lenox","year":"1992","journal-title":"Brain Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1177\/0269881109359102","article-title":"The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: role of brain-derived neurotrophic factor","volume":"24","author":"Li","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"B71","article-title":"\u201cUsing motor and prefrontal cortex interleaved transcranial magnetic stimulation (TMS) BOLD fMRI to compare the mechanism of action of lamotrigine to valproic acid in normal volunteers,\u201d","volume-title":"Proceedings of the 45th American College of Neuropsychopharmacology Annual Meeting","author":"Li","year":"2006"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/sj.npp.1300452","article-title":"Interleaved transcranial magnetic stimulation\/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4088\/JCP.v69n0108","article-title":"Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine","volume":"69","author":"Lin","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"B74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.biopsych.2003.09.017","article-title":"Serotonin 5-HT1A, 5-HT1B and 5-HT2A, receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia","volume":"55","author":"Lopez-Figueroa","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pnpbp.2003.10.015","article-title":"Perspectives for the development of animal models of bipolar disorder","volume":"28","author":"Machado-Vieira","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0014-2999(98)00554-8","article-title":"PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat","volume":"359","author":"Maj","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jad.2009.02.027","article-title":"Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients","volume":"119","author":"Mandelli","year":"2009","journal-title":"J. Affect. Disord."},{"key":"B78","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1528-1157.1999.tb00711.x","article-title":"Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation","volume":"40","author":"Manganotti","year":"1999","journal-title":"Epilepsia"},{"key":"B79","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pbiomolbio.2004.06.004","article-title":"Mechanisms underlying gamma (\u201840 Hz\u2019) network oscillations in the hippocampus: a mini-review","volume":"87","author":"Mann","year":"2005","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1358\/mf.2001.23.1.619175","article-title":"\u03b12-Adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming","volume":"23","author":"Masuda","year":"2001","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"B81","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-3565(24)29479-9","article-title":"Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice","volume":"298","author":"Mayorga","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","article-title":"Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex","volume":"168","author":"Michael","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0893-133X(95)00072-L","article-title":"Effects of \u03b1-methyl-p-tyrosine (AMPT) in drug-free depressed patients","volume":"14","author":"Miller","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1176\/appi.ajp.163.2.210","article-title":"Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone","volume":"163","author":"Nierenberg","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"B85","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4088\/JCP.v63n0411","article-title":"Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study","volume":"63","author":"Normann","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"B86","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/026988110101500104","article-title":"Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice","volume":"15","author":"O\u2019Neill","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12427","article-title":"The \u2018disconnect\u2019 between initial judgments of lamotrigine vs. its real-world effectiveness in managing bipolar disorder. A tale with wider ramifications","author":"Parker","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"B88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.brs.2008.06.002","article-title":"State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation","volume":"1","author":"Paulus","year":"2008","journal-title":"Brain Stimul."},{"key":"B89","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1146\/annurev.pharmtox.41.1.789","article-title":"Molecular targets of lithium action","volume":"41","author":"Phiel","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.4088\/jcp.10060tx2cc","article-title":"Review of current bipolar disorder treatment guidelines","volume":"73","author":"Podawiltz","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"B92","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"B93","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2165\/00023210-199708050-00002","article-title":"Drug-induced switching in bipolar disorder","volume":"8","author":"Post","year":"1997","journal-title":"CNS Drugs"},{"key":"B94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2008.03.007","article-title":"Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression","volume":"191","author":"Prica","year":"2008","journal-title":"Behav. Brain. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1471-4159.2007.04648.x","article-title":"Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2","volume":"102","author":"Rao","year":"2007","journal-title":"J. Neurochem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"B97","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/archpsyc.59.7.592","article-title":"Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?","volume":"59","author":"Rapoport","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.brainresrev.2009.06.003","article-title":"Bipolar disorder and mechanisms of action of mood stabilizers","volume":"61","author":"Rapoport","year":"2009","journal-title":"Brain Res. Rev."},{"key":"B99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s002130050846","article-title":"Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate","volume":"141","author":"Redrobe","year":"1999a","journal-title":"Psychopharmacology (Berl.)"},{"key":"B101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1092852900011573","article-title":"Augmentation of antidepressant pharmacotherapy: a preclinical approach using the forced swimming test","volume":"4","author":"Redrobe","year":"1999b","journal-title":"CNS Spectr."},{"key":"B102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0014-2999(96)00772-8","article-title":"The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test","volume":"318","author":"Redrobe","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"675","DOI":"10.4088\/JCP.12r08046","article-title":"Lamotrigine in psychiatric disorders","volume":"74","author":"Reid","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"B104","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004850-200303000-00006","article-title":"Lamotrigine augmentation in unipolar depression","volume":"18","author":"Rocha","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1017\/S1092852900006349","article-title":"The therapeutic potential of 5-HT1B autoreceptors and heteroreceptors and 5-HT moduline in CNS disorders","volume":"3","author":"Sarhan","year":"1998","journal-title":"CNS Spectr."},{"key":"B106","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jad.2006.05.023","article-title":"Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression","volume":"96","author":"Schaffer","year":"2006","journal-title":"J. Affect. Disord."},{"key":"B107","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sj.npp.1301575","article-title":"Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Schloesser","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jad.2008.01.029","article-title":"Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review","volume":"111","author":"Sharma","year":"2008","journal-title":"J. Affect. Disord."},{"key":"B109","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/jpet.113.203315","article-title":"Modulation of the antidepressant-like effects of sustained administration of carisbamate and lamotrigine on monoaminergic systems: electrophysiological studies in the rat brain","volume":"347","author":"Shim","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bdi.12026","article-title":"Evidence-based treatment strategies for treatment-resistant bipolar depression: a systematic review","volume":"15","author":"Sienaert","year":"2013","journal-title":"Bipolar Disord."},{"key":"B111","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.neuropharm.2006.09.002","article-title":"Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings","volume":"52","author":"Sitges","year":"2007a","journal-title":"Neuropharmacology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.neuropharm.2007.08.016","article-title":"Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release","volume":"53","author":"Sitges","year":"2007b","journal-title":"Neuropharmacology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study","volume":"68","author":"Souery","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"B114","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","article-title":"Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats","volume":"358","author":"Southam","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0027-5107(01)00206-8","article-title":"Glutathione-S-transferase family of enzymes","volume":"482","author":"Strange","year":"2001","journal-title":"Mutat. Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0091-3057(88)90316-4","article-title":"Alpha noradrenergic agonists promote catalepsy in the mouse","volume":"31","author":"Sukul","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B117","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejphar.2004.01.008","article-title":"Effect of combined administration of 5-HT1A or 5-HT1B\/D receptor antagonists and antidepressants in the forced swimming test","volume":"487","author":"Tatarczynska","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eplepsyres.2003.08.006","article-title":"Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation","volume":"56","author":"Tergau","year":"2003","journal-title":"Epilepsy Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/s-0035-1559635","article-title":"Retrospective analysis of therapeutic drug monitoring data for treatment of bipolar disorder with lamotrigine","volume":"48","author":"Unholzer","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"B120","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4088\/JCP.08m04152","article-title":"Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial","volume":"70","author":"van der Loos","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"B121","first-page":"159","article-title":"The role of third generation anticonvulsants in the treatment of bipolar disorder","volume":"3","author":"Vieta","year":"2004","journal-title":"Clin. Neuropsychiatry"},{"key":"B122","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1399-5618.2007.00561.x","article-title":"Bipolar II disorder: arguments for and against a distinct diagnostic entity","volume":"10","author":"Vieta","year":"2008","journal-title":"Bipolar Disord."},{"key":"B123","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0197-0186(01)00088-2","article-title":"Lamotrigine induced selective changes in 5-HT1A receptor mediated response in rat brain","volume":"40","author":"Vinod","year":"2002","journal-title":"Neurochem. Int."},{"key":"B124","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1471-4159.1996.67020767.x","article-title":"Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation","volume":"67","author":"Watson","year":"1996","journal-title":"J. Neurochem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000026527","article-title":"Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder","volume":"38","author":"Xie","year":"1998","journal-title":"Neuropsychobiology"},{"key":"B126","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/BF00373920","article-title":"Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones","volume":"430","author":"Xie","year":"1995","journal-title":"Pflugers Arch."},{"key":"B127","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord."},{"issue":"Suppl. 2","key":"B128","first-page":"87S","article-title":"Bipolar depression: treatment options","volume":"42","author":"Yatham","year":"1997","journal-title":"Can. J. Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"31674","DOI":"10.1074\/jbc.M104309200","article-title":"The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth","volume":"276","author":"Yuan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B130","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1196\/annals.1300.017","article-title":"Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system","volume":"1003","author":"Zarate","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T03:37:27Z","timestamp":1748662647000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2015.00242\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":130,"URL":"https:\/\/doi.org\/10.3389\/fphar.2015.00242","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]}}}